15 Stocks That Could Mint Millionaires in 2026

Page 3 of 13

11. Corcept Therapeutics Incorporated (NASDAQ:CORT)

Number of Hedge Fund Holders: 28

Next Year Revenue Growth: 38%

Next Year EPS Growth: 103%

Analyst Upside: 76%

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the stocks that could mint millionaires in 2026.

On December 16, UBS analyst Ashwani Verma initiated coverage of Corcept Therapeutics Incorporated (NASDAQ:CORT) stock with a Neutral rating and $95 price target. In an investor note, the analyst cited valuation for the Neutral rating, with the shares up 64% year-to-date. Per the analyst, the stock was already pricing in both the continued growth in hypercortisolism and Corcept’s new launch opportunity in platinum-resistant ovarian cancer.

In early November, the company posted earnings for the third quarter of 2025, reporting earnings per share of $0.16, beating market estimates by $0.02. The revenue over the period was more than $207 million, up close to 14% compared to the revenue over the same period last year and missing analyst expectations by close to $11 million. The firm also modified 2025 revenue guidance of $800 to $850 million versus the $852 million consensus.

Corcept Therapeutics Incorporated (NASDAQ:CORT) engages in the discovery and development of medications for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Page 3 of 13